These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 26132727)
41. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma. Park BK; Paik YH; Park JY; Park KH; Bang S; Park SW; Chung JB; Park YN; Song SY Am J Clin Oncol; 2006 Apr; 29(2):138-42. PubMed ID: 16601431 [TBL] [Abstract][Full Text] [Related]
42. High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma. Huang Y; Kong Y; Zhang L; He T; Zhou X; Yan Y; Zhang L; Zhou D; Lu S; Zhou J; Zhou L; Xie H; Zheng S; Wang W Biomed Res Int; 2018; 2018():2352139. PubMed ID: 29511671 [TBL] [Abstract][Full Text] [Related]
43. Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patients. Huang XY; Zhang C; Cai JB; Shi GM; Ke AW; Dong ZR; Zhang PF; Fan J; Peng BG; Zhou J PLoS One; 2014; 9(5):e96860. PubMed ID: 24816558 [TBL] [Abstract][Full Text] [Related]
44. High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery. Shi RY; Yang XR; Shen QJ; Yang LX; Xu Y; Qiu SJ; Sun YF; Zhang X; Wang Z; Zhu K; Qin WX; Tang ZY; Fan J; Zhou J Cancer; 2013 Mar; 119(5):993-1003. PubMed ID: 23132676 [TBL] [Abstract][Full Text] [Related]
45. Association of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppression. Igarashi T; Araki K; Yokobori T; Altan B; Yamanaka T; Ishii N; Tsukagoshi M; Watanabe A; Kubo N; Handa T; Hosouchi Y; Nishiyama M; Oyama T; Shirabe K; Kuwano H Oncotarget; 2017 Feb; 8(7):12290-12300. PubMed ID: 28103577 [TBL] [Abstract][Full Text] [Related]
46. High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma. Jin J; Ryu HS; Lee KB; Jang JJ PLoS One; 2014; 9(2):e90247. PubMed ID: 24587299 [TBL] [Abstract][Full Text] [Related]
47. MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis. Huang Q; Liu L; Liu CH; You H; Shao F; Xie F; Lin XS; Hu SY; Zhang CH Asian Pac J Cancer Prev; 2013; 14(2):829-34. PubMed ID: 23621247 [TBL] [Abstract][Full Text] [Related]
48. Expression profile of microRNA-200 family in cholangiocarcinoma arising from choledochal cyst. Chu CH; Chou W; Wang F; Yeh CN; Chen TC; Yeh TS J Gastroenterol Hepatol; 2016 May; 31(5):1052-9. PubMed ID: 26479153 [TBL] [Abstract][Full Text] [Related]
49. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients. Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940 [TBL] [Abstract][Full Text] [Related]
50. Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines. Zhong Z; Zhou F; Wang D; Wu M; Zhou W; Zou Y; Li J; Wu L; Yin X Oncol Rep; 2018 Dec; 40(6):3852-3860. PubMed ID: 30542730 [TBL] [Abstract][Full Text] [Related]
51. The E-cadherin repressor slug and progression of human extrahepatic hilar cholangiocarcinoma. Zhang KJ; Wang DS; Zhang SY; Jiao XL; Li CW; Wang XS; Yu QC; Cui HN J Exp Clin Cancer Res; 2010 Jul; 29(1):88. PubMed ID: 20594328 [TBL] [Abstract][Full Text] [Related]
52. C-Reactive Protein (CRP) is a Promising Diagnostic Immunohistochemical Marker for Intrahepatic Cholangiocarcinoma and is Associated With Better Prognosis. Yeh YC; Lei HJ; Chen MH; Ho HL; Chiu LY; Li CP; Wang YC Am J Surg Pathol; 2017 Dec; 41(12):1630-1641. PubMed ID: 28945626 [TBL] [Abstract][Full Text] [Related]
54. The clinical significance and biological function of interferon regulatory factor 1 in cholangiocarcinoma. Wan P; Zhang J; Du Q; Geller DA Biomed Pharmacother; 2018 Jan; 97():771-777. PubMed ID: 29107934 [TBL] [Abstract][Full Text] [Related]
55. HSPB8 promoted intrahepatic cholangiocarcinoma progression by enhancing epithelial-mesenchymal transition and autophagy. Shu B; Zhou Y; Liang Q; He C; Li F Exp Mol Pathol; 2021 Dec; 123():104691. PubMed ID: 34606781 [TBL] [Abstract][Full Text] [Related]
56. E-cadherin gene mutations in human intrahepatic cholangiocarcinoma. Endo K; Ashida K; Miyake N; Terada T J Pathol; 2001 Mar; 193(3):310-7. PubMed ID: 11241409 [TBL] [Abstract][Full Text] [Related]
58. Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma. Xie N; Cai JB; Zhang L; Zhang PF; Shen YH; Yang X; Lu JC; Gao DM; Kang Q; Liu LX; Zhang C; Huang XY; Zou H; Zhang XY; Song ZJ; Sun HX; Fu BM; Ke AW; Shi GM Cell Death Dis; 2017 Dec; 8(12):3205. PubMed ID: 29235470 [TBL] [Abstract][Full Text] [Related]
59. Adrenomedullin promotes intrahepatic cholangiocellular carcinoma metastasis and invasion by inducing epithelial-mesenchymal transition. Zhou C; Zheng Y; Li L; Zhai W; Li R; Liang Z; Zhao L Oncol Rep; 2015 Aug; 34(2):610-6. PubMed ID: 26043778 [TBL] [Abstract][Full Text] [Related]
60. Characterization of EGFR family gene aberrations in cholangiocarcinoma. Yang X; Wang W; Wang C; Wang L; Yang M; Qi M; Su H; Sun X; Liu Z; Zhang J; Qin X; Han B Oncol Rep; 2014 Aug; 32(2):700-8. PubMed ID: 24927194 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]